Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Galaxy Surfactants Ltd

| Q3 FY26 Earnings Conference Call

NEUTRAL SENTIMENT

Report Source

⬤23rd Feb 26

Summary : Galaxy Surfactants faced Q3 headwinds from reformulation and high raw material costs but anticipates recovery driven by U.S. tariff reductions, new product launches, and diversified customer engagement.

Management Perspective positive : Management acknowledges challenges but expresses confidence in recovery, citing tariff reductions, new product launches, and strategic customer diversification. Phrases like 'strongly welcomes the state development,' 'confident that the worst is behind us,' and 'confident of regaining our growth momentum' indicate a positive outlook despite recent headwinds.

Concall Report Analysis & Insights

Business Overview

  1. Q3 FY26 saw multiple headwinds, including reformulation pressures and high feedstock prices.
  2. Consolidated volumes were stable year-on-year, with Specialty segment growing high single-digit.
  3. Performance Surfactants declined high single-digit due to Tier 1 account reformulation in India.
  4. EBITDA increased 13% year-on-year to INR124 crores, with EBITDA per metric ton improving.
  5. Growth driven by non-Tier 1 customers, Masstige/Prestige products, EPC projects, and cost efficiency.

Future Growth Prospects

  1. U.S. reciprocal tariff reduction from 50% to 18% will restore competitiveness and rebuild traction.
  2. Expect commercialization of alternate surfactant systems in India from Q4 FY26.
  3. Anticipate double-digit volume growth in the specialty segment to continue.
  4. Launched 5 new products in Sun Care and Leave-on segments, commercializing from Q4 FY26.
  5. AMET region expects volume recovery from Q4 onwards, a high priority for the company.

Management Insights

  1. Q3 FY26 was challenging, with multiple headwinds converging, testing agility and execution.
  2. The U.S. tariff reduction is a major structural positive, strengthening long-term North America position.
  3. Confident that the worst is behind us, with India growth improving and AMET volumes recovering.
  4. Reformulation by Tier 1 customers is temporary; expect reversion to original formulations when fatty alcohol prices normalize.
  5. Strategic focus on engaging Tier 2, Tier 3, and D2C customers mitigated Tier 1 impact.

Signs of Skepticism

  1. Management could not quantify the exact contribution of the EPC segment due to confidentiality.
  2. Uncertainty remains on how much of the 35% peak AMET volumes can be recovered in the next 1-1.5 years.
  3. Specific details on the differential between fatty alcohol and crude petroleum prices were not readily available.
  4. The long-term structural shift in fatty alcohol prices is still uncertain, requiring observation until October.

Risk Factors

  1. Persistently high fatty alcohol prices continue to drive reformulation risk and impact volumes.
  2. Temporary demand disruption in India due to GST rate rationalization and inventory adjustments.
  3. Heightened competitive intensity in AMET, including backward-integrated local players, led to market share loss.
  4. U.S. customers flagging demand issues in Beauty and Well-being segments, requiring careful monitoring.
  5. Fluctuating raw material prices and short-term customer deals increase risk management complexity.

Good To Know

  1. Galaxy refreshed its brand identity in January '26, emphasizing long-term partnerships and sustainable value creation.
  2. The company is expanding its portfolio beyond home and personal care into beauty, derma, and wellness segments.
  3. Exceptional items of INR11.9 crores were recognized for new labor code adjustments (gratuity, leave encashment).
  4. The EPC project is strategic for gaining access to Performance Surfactants volumes in North America.
  5. The company maintains a robust risk management framework for raw material price fluctuations.

Key Drivers

  1. US tariff reduction boosts exports.
  2. New specialty products commercialize soon.
  3. India market growth trajectory improves.
  4. AMET volumes expected to recover.

Key Analyst Discussions

Competitive Environment

  1. Analysts asked about the competitive intensity in AMET and the ability to recover lost volumes.
  2. Management explained AMET market share loss to backward-integrated local players due to currency depreciation in Egypt.
  3. The company is pivoting to other AMET markets and balancing credit risk to regain volumes.
  4. Management does not expect to recover peak AMET volumes due to the changed competitive scenario.

Market Trends & Consumer Behavior

  1. Questions arose about the impact of GST rationalization on India's market growth and customer inventory adjustments.
  2. Management noted U.S. customers are flagging demand issues in Beauty and Well-being segments.
  3. Discussion on whether fatty alcohol price volatility is a structural shift or temporary, with expectation of price correction from May.
  4. Customers are making short-term deals (1-3 months) for raw materials due to price uncertainty.

Financial Highlights

  1. Analysts questioned the significant jump in other comprehensive income, attributed to exchange rate movements from subsidiary adjustments.
  2. Queries on EPC segment's contribution to margins were met with management stating it's not significant on a YTD basis.
  3. Discussion on gross margin improvement in Q3 (INR53-53.5/kg) compared to H1 (INR49/kg) due to mix and TRI-K performance.
  4. Management confirmed a robust risk management framework minimizes P&L impact from significant raw material price drops.

Product Composition

  1. Analysts inquired about the shift in revenue mix towards local niche players (Tier 2, Tier 3, D2C).
  2. Management clarified this shift is partly due to Tier 1 volume decline and strategic engagement with diverse customer segments.
  3. New products in Sun Care and Leave-on segments are expected to have significantly higher EBITDA per tonne.
  4. The company is focused on expanding into the beauty segment with ingredients for skin cream and lotions.

Strategic Considerations

  1. Questions on the timeline for commercialization of new formulations in India and expected double-digit growth.
  2. Inquiries about the strategic benefits of the EPC project beyond immediate earnings, focusing on North America market access.
  3. Analysts asked if the company's volume guidance of 6-8% for the next two years is still maintained despite market flux.
  4. Discussion on the impact of U.K. and EU FTAs on cost competency, with EU FTA expected to reduce duties to 0%.
Galaxy Surfactants Ltd (GALAXYSURF) Concall Report Analysis & Insights | Dhanarthi